Voloridge Investment Management
ARNA

Voloridge Investment Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Voloridge Investment Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-61,909
Closed -$5.75M – 1825
2021
Q4 		$5.75M Buy
+61,909
New +$4.08M 0.03% 665
2020
Q1 		– Sell
-24,021
Closed -$1.09M – 1507
2019
Q4 		$1.09M Buy
+24,021
New +$1.14M 0.02% 629

Voloridge Investment Management's ARNA Position: Q1 2022 in Review

Voloridge Investment Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 61,909 shares — an estimated $5.75M sold.

Voloridge Investment Management first reported a position in ARNA in Q4 2019 and held it in 2 quarters. The position peaked at $5.75M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Voloridge Investment Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 61,909 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $5.75M.
  • Voloridge Investment Management first reported a position in Arena Pharmaceuticals Inc in Q4 2019 and held it in 2 quarters.
  • Voloridge Investment Management's Arena Pharmaceuticals Inc position peaked at $5.75M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Voloridge Investment Management's 13F filing for Q1 2022, filed 16 May 2022.